P14.59 Post-Market Surveillance Data of the EMEA region indicate good tolerability of TTFields in WHO Grade III Glioma

Authors: A F Keßler, R Ritz

Published: 2019-09-06

DOI: 10.1093/neuonc/noz126.294

Source: Full article


Abstract

Abstract